In memoriam: Norman Meadow
Norman Meadow, a professor of biochemistry at Johns Hopkins University, died July 23, 2024, at the age of 87 in Maryland. He was a member of the American Society for Biochemistry and Molecular Biology for 34 years.
Born in May 1937, Meadow obtained his Ph.D. from the University of Pennsylvania before becoming a faculty member at Johns Hopkins University, where he served for three decades performing protein phosphorylation and bacterial signal transduction research.
Meadow's scientific contributions significantly advanced the field’s understanding of the bacterial phosphotransferase system, PTS. His work with Saul Roseman led to the isolation and characterization of the glucose-specific bacterial phosphocarrier protein IIIGlc and its role in sugar transport. He also contributed to understanding glucose transport kinetics within the PTS framework and pioneered a technique to characterize kinase–substrate interactions.
He is survived by his wife, Karen; three children, Max, Paul and David; and six grandchildren. He was predeceased by his parents, Mary and Paul, and brother, Harold.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in People
People highlights or most popular articles
In memoriam: Ralph G. Yount
He was a professor emeritus of chemistry and biochemistry at Washington State University and an ASBMB member for 58 years.
From dust to discovery
From makeshift classrooms in Uganda to postdoctoral research in Chicago, MOSAIC scholar Elizabeth Kaweesa builds a legacy in women’s health.
Fliesler wins scientific and ethical awards
He is being honored by the University at Buffalo and the American Oil Chemists' Society for his scientific achievements and ethical integrity.
Hope for a cure hangs on research
Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson’s fight for survival and hope. Without funding, science can’t “catch up” to help the patients who need it most.
Before we’ve lost what we can’t rebuild: Hope for prion disease
Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal — and just getting started.
ASBMB members recognized as Allen investigators
Ileana Cristea, Sarah Cohen, Itay Budin and Christopher Obara are among 14 researchers selected as Allen Distinguished Investigators by the Paul G. Allen Family Foundation.